Article: New 'Zomig' Nasal Spray Provides Migraine Sufferers With Fastest Patient-Friendly Relief.

VIENNA, Austria -- A new, very fast acting formulation of the leading second-generation triptan, zolmitriptan, is now available allowing millions of European migraine sufferers to treat their debilitating and painful condition both rapidly and reliably. 'Zomig' Nasal Spray offers patients a highly effective, well-tolerated alternative to conventional tablets and sub-cutaneaous injections according to migraine experts speaking at the European Federation of Neurological Societies (EFNS) meeting today.

"The clinical trial data for Zomig Nasal Spray suggest that this new formulation offers patients and physicians a significant advance in migraine therapy", points out ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!